Zheng Quan Zhi Xing·2025-08-04 00:08Group 1: Aojie Technology - Aojie Technology has made significant progress in ASIC business, RedCap chips, and 4G/5G smartphone chips [1] - The ASIC business is focused on smart wearables, edge SOC, RISC-V, and cloud inference chips, with expected substantial revenue growth by 2026 [1] - RedCap chips are commercially available in the IoT market, and the company has production capabilities in the smart wearable market [1] - The company has successfully commercialized 4G quad-core chips and is making steady progress in the development of 4G octa-core, 6nm 4G octa-core, and 6nm 5G octa-core chips [1] - Aojie Technology plans to control the growth of operating and R&D expenses to no more than 15% and has no plans for convertible bond issuance or Hong Kong listing [1] Group 2: Haoyuan Pharmaceutical - Haoyuan Pharmaceutical is committed to a global development strategy, with international business revenue expected to account for nearly 40% in 2024 [1] - The company has established collaborations with multinational pharmaceutical giants, universities, research institutes, and CROs [1] - The net operating cash flow is projected to turn positive to 380 million yuan in 2024, with continued focus on cash flow management in 2025 [1] - The company has a strong presence in the ADC field, with the Chongqing ADC CDMO factory providing one-stop services [1] - Haoyuan Pharmaceutical emphasizes ESG practices, having established an ESG governance framework and received multiple ESG awards [1] Group 3: Chongda Technology - Chongda Technology anticipates positive growth in the global PCB market by 2025, with strong order demand and rising product prices [2] - The company's capacity utilization rate is at 85%, with new production capacities being added in Zhuhai and Thailand [2] - To improve profitability, Chongda Technology is focusing on high-value customers, optimizing sales structure, and enhancing cost management [2] - The company is implementing a structural price increase strategy to address rising raw material costs [2] - The U.S. market accounts for 10% of the company's revenue, and it is adopting strategies to diversify markets and optimize customer cooperation in response to tariff policy changes [2]